LivingGLP1
Study S000219

Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus, a Retrospective Chart Review

Registration

Registration
NCT01299012
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
30
Start
2010-10
Primary completion
2013-02
Lead sponsor
University at Buffalo
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:Liraglutide
Results posted
FALSE

Registered primary outcomes

  • Improved Blood Glucose comtrol in Type 1 Diabetes Patients with Liraglutide [20 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.